V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001271 | 230000871 | 1.76 | 152 | Curative (C) | 2013-06-28 | 2013-06-28 | Capecitabine | 02 | N | 230007089 | TRASTUZUMAB |
| 230001272 | 230001379 | 1.86 | 87.2 | null | 2015-10-14 | 2015-10-14 | Irinotecan + Modified De Gramont | 02 | N | 230007118 | OXALIPLATIN + MDG |
| 230001273 | 230000875 | 1.63 | 67.75 | Curative (C) | 2014-09-24 | 2014-09-30 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 230007118 | RITUXIMAB |
| 230001274 | 230000876 | 1.54 | 44 | Palliative (P) | 2017-03-01 | 2017-03-12 | Irinotecan + Modified De Gramont | 02 | N | 230007151 | CARBOPLATIN + PEMETREXED |
| 230001275 | 230000878 | 1.66 | 63.1 | Adjuvant (A) | 2014-10-30 | 2014-10-30 | CAPECITABINE + OXALIPLATIN | 2 | N | 230007216 | CARBOPLATIN |
| 230001276 | 230000879 | 1.57 | 49.3 | Neo-adjuvant (N) | 2015-01-09 | 2015-01-16 | Cisplatin + Radiotherapy | 2 | N | 230007340 | OXALIPLATIN + MDG |
| 230001277 | 230000879 | 1.56 | 51.7 | Disease modification (D) | 2017-07-22 | 2017-08-03 | Sorafenib | 2 | N | 230007340 | DOCETAXEL |
| 230001278 | 230001690 | 1.72 | 87.3 | Curative (C) | 2015-07-24 | 2015-08-01 | Capecitabine + Cisplatin + RT | N | N | 230007459 | MPT |
| 230001279 | 230000880 | 1.65 | 67 | Neo-adjuvant (N) | 2017-12-19 | 2017-12-21 | Irinotecan + Modified De Gramont | N | N | 230007468 | TRABECTEDIN |
| 230001280 | 230000882 | null | 92.9 | null | 2016-05-15 | 2016-05-24 | FLUOROURACIL + OXALIPLATIN | N | N | 230007490 | CISPLATIN + ETOPOSIDE + RT |
| 230001281 | 230000884 | 1.63 | 69.1 | Adjuvant (A) | 2018-02-24 | 2018-03-03 | Trastuzumab Subcutaneous | 2 | N | 230007554 | LEAM |
| 230001282 | 230000889 | 1.66 | 51.7 | Palliative (P) | null | 2013-11-13 | IVE | N | null | 230007563 | TRIFLURIDINE + TIPIRACIL |
| 230001283 | 230001384 | 1.73 | 56.2 | Disease modification (D) | 2014-08-30 | 2014-09-12 | Trial Unspecified | N | N | 230007606 | ERIBULIN |
| 230001284 | 230000892 | 1.9 | 92.9 | Palliative (P) | 2017-03-19 | 2017-04-03 | Oxaliplatin + Modified de Gramont | 02 | N | 230007606 | IRINOTECAN + MDG |
| 230001285 | 230000894 | 1.53 | 71.6 | Adjuvant (A) | 2017-07-22 | 2017-07-22 | CARBOPLATIN + PACLITAXEL | 2 | N | 230007737 | FLUOROURACIL + MITOMYCIN + RT |
| 230001286 | 230000894 | 1.61 | 50 | Palliative (P) | 2013-12-02 | 2014-01-06 | AFLIBERCEPT + FU + IRINOTECAN | N | null | 230007737 | CAPECITABINE + RT |
| 230001287 | 230001598 | 1.53 | 69.1 | Curative (C) | 2013-07-05 | 2013-07-24 | BEVACIZUMAB + FLUOROURACIL | N | null | 230008053 | CISPLATIN + GEMCITABINE |
| 230001288 | 230000895 | null | 69.8 | Palliative (P) | 2017-02-28 | 2017-03-12 | CETUXIMAB + IRINOTECAN | N | null | 230008108 | CAPECITABINE + TEMOZOLOMIDE |
| 230001289 | 230000895 | 1.66 | 50.9 | Palliative (P) | 2016-12-17 | 2017-01-03 | CHOP R - 21 days | N | N | 230008108 | IVA |
| 230001290 | 230001388 | 1.68 | 64.7 | Palliative (P) | 2018-05-30 | 2019-04-20 | Cisplatin + Docetaxel | 2 | N | 230008211 | NINTEDANIB |
| 230001291 | 230001388 | 1.66 | 85.9 | null | 2014-10-01 | 2014-10-14 | FLUOROURACIL + OXALIPLATIN | 02 | N | 230008211 | PEMETREXED |
| 230001292 | 230000898 | 1.9 | 66 | Palliative (P) | 2017-05-19 | 2017-05-20 | Bevacizumab 5mg/kg | 02 | N | 230008316 | IRINOTECAN + MDG |
| 230001293 | 230000902 | 1.63 | 71.6 | Palliative (P) | 2018-08-26 | 2018-10-06 | Capecitabine | N | N | 230008383 | VANDETANIB |
| 230001294 | 230000903 | 1.59 | 51.8 | Palliative (P) | 2015-11-17 | 2015-12-19 | Fluorouricil + Folonic Acid (MdG) | 2 | N | 230008396 | LENVATINIB |
| 230001295 | 230000904 | 1.73 | 79 | Not known (9) | 2016-02-29 | 2016-09-21 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 230008401 | BENDAMUSTINE + RITUXIMAB |
| 230001296 | 230001392 | 1.79 | 69.6 | Adjuvant (A) | 2016-09-15 | 2016-05-27 | ETOPOSIDE | N | N | 230008413 | FLUOROURACIL |
| 230001297 | 230000905 | 1.54 | null | Adjuvant (A) | 2017-05-12 | 2017-06-03 | Methotrexate intrathecal | N | N | 230008421 | CAPECITABINE + OXALIPLATIN |
| 230001298 | 230001393 | 1.59 | 61.7 | Curative (C) | 2017-08-05 | 2017-08-05 | Capecitabine + Oxaliplatin 21day | 02 | null | 230008421 | CISPLATIN + VINORELBINE |
| 230001299 | 230000908 | 1.82 | 93.95 | Palliative (P) | 2019-02-06 | 2019-02-09 | Capecitabine | N | N | 230008664 | AFLIBERCEPT + FU + IRINOTECAN |
| 230001300 | 230000909 | 1.76 | 55 | Palliative (P) | 2017-11-26 | 2017-11-26 | Methotrexate High Dose (3g/m2) | N | null | 230008715 | TRIAL |
| 230001301 | 230000910 | 1.58 | 63.6 | Palliative (P) | 2017-03-12 | 2017-04-03 | Capecitabine + Oxaliplatin 21day | 2 | N | 230008715 | ABIRATERONE |
| 230001302 | 230000910 | 1.71 | 100.6 | Disease modification (D) | 2016-02-09 | 2016-02-23 | FLUOROURACIL + MITOMYCIN + RT | 2 | N | 230008715 | TRIAL |
| 230001303 | 230000910 | 1.59 | 58 | Curative (C) | 2015-08-24 | 2015-08-24 | PACLITAXEL | 02 | N | 230008715 | CHOP R |
| 230001304 | 230001725 | 1.52 | 59.7 | Adjuvant (A) | 2017-09-03 | 2017-09-18 | Cetuximab + FOLFIRI cycle 2 onwards | N | null | 230009054 | CTD |
| 230001305 | 230000912 | 1.88 | 91.7 | Palliative (P) | 2015-02-17 | 2015-02-17 | Mitomycin Intravesical | 02 | N | 230009056 | CARBOPLATIN + PEMETREXED |
| 230001306 | 230000913 | 1.76 | 96.5 | Palliative (P) | 2018-02-06 | 2018-03-10 | Capecitabine + Oxaliplatin 21day | N | N | 230009139 | IGEV R |
| 230001307 | 230000915 | null | 59 | Palliative (P) | 2016-06-21 | 2016-07-31 | Rituximab (Maintenance) | null | N | 230009272 | OXALIPLATIN + MDG |
| 230001308 | 230000916 | 1.64 | null | Palliative (P) | 2019-03-02 | 2019-04-19 | LEAM | 02 | N | 230009388 | CARBOPLATIN + PACLITAXEL |
| 230001309 | 230000918 | 1.58 | 75.75 | Palliative (P) | 2017-12-22 | 2017-12-29 | FLUOROURACIL + OXALIPLATIN | 02 | N | 230009458 | SORAFENIB |
| 230001310 | 230001396 | 1.7 | 89.9 | Palliative (P) | 2014-09-24 | 2014-09-26 | Folfirinox | 2 | N | 230009647 | CISPLATIN + VINORELBINE |
| 230001311 | 230000921 | 1.65 | 96.5 | Curative (C) | 2016-06-28 | 2016-06-28 | CETUXIMAB | 02 | N | 230009672 | R-EPOCH |
| 230001312 | 230000923 | null | 72.8 | Palliative (P) | 2015-09-02 | 2015-09-14 | Capecitabine + Oxaliplatin 21day | N | N | 230009744 | TRASTUZUMAB |
| 230001313 | 230001604 | 1.68 | 73 | Curative (C) | 2018-07-17 | 2018-10-10 | PACLITAXEL | 02 | N | 230009779 | FLUOROURACIL |
| 230001314 | 230000924 | 1.7 | 72.4 | Palliative (P) | 2019-07-10 | 2019-07-18 | CVP R | 02 | N | 230009950 | CETUXIMAB |
| 230001315 | 230001398 | 1.76 | 83.3 | Curative (C) | 2014-12-31 | 2015-01-01 | Capecitabine + Oxaliplatin 21day | 2 | N | 230010075 | TRABECTEDIN |
| 230001316 | 230000925 | 1.57 | 56.25 | Palliative (P) | 2015-07-16 | 2015-07-16 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | Y | 230010381 | LENVATINIB |
| 230001317 | 230000928 | 1.64 | 50.6 | Palliative (P) | 2016-01-03 | 2016-10-19 | Rituximab | N | null | 230010751 | LENVATINIB |
| 230001318 | 230001400 | 1.6 | null | Palliative (P) | 2017-10-01 | 2017-10-02 | Methotrexate intrathecal | 02 | N | 230010756 | METHOTREXATE INTRATHECAL |
| 230001319 | 230001400 | null | 59.7 | Adjuvant (A) | 2017-07-04 | 2017-07-04 | Docetaxel | N | N | 230010756 | PACLITAXEL |
| 230001320 | 230000929 | 1.64 | 82 | Adjuvant (A) | 2017-10-03 | 2017-10-09 | Capecitabine | 02 | N | 230011074 | PACLITAXEL |